Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Proudlove

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
British Journal of Nursing (Mark Allen Publishing)|November 3, 2010
The Injectable Medicines Guide WebsiteSusan Keeling, Robin Burfield, Christine Proudlove, et al.
Pharmacoeconomics|May 15, 2010
Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisalAdrian Bagust, Janette Greenhalgh, Angela Boland, et al.
Health Technology Assessment (Winchester, England)|July 3, 2015
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluationJanette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
British Journal of Nursing (Mark Allen Publishing)|November 3, 2010
The Injectable Medicines Guide WebsiteSusan Keeling, Robin Burfield, Christine Proudlove, et al.
Pharmacoeconomics|May 15, 2010
Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisalAdrian Bagust, Janette Greenhalgh, Angela Boland, et al.
Health Technology Assessment (Winchester, England)|July 3, 2015
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluationJanette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Pageof 1